Min, Seihee
Yoon, Susie
Han, Jiwon
Seo, Jeong-Hwa
Bahk, Jae-Hyon
Article History
Received: 4 October 2024
Accepted: 25 December 2024
First Online: 9 January 2025
Declarations
:
: This prospective, randomized, crossover study was approved by the Institutional Review Board of Seoul National University Hospital (IRB No. 1509-113-705; Principal Investigator, Jae-Hyon Bahk; 25/08/2016) and registered at ClinicalTrials.gov (NCT02981537, 05/12/2016) prior to patient enrollment. Written informed consent was obtained from all participants. The study was conducted in accordance with the Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. All participants provided written informed consent and could withdraw consent at any time.
: Not applicable.
: The authors declare no competing interests.